Stephen Jaeger
Chief Tech/Sci/R&D Officer chez TRAUMHAUS AG
Profil
Stephen O.
Jaeger is currently working as a Manager-Technical at Traumhaus AG.
Previously, he worked as Chairman & Chief Executive Officer at eBT International, Inc. from 1999 to 2005.
He also served as a Director at Aradigm Corp.
from 2003 to 2008 and as an Independent Director at DARA BioSciences, Inc. from 2012 to 2013.
Additionally, he worked as the Chief Financial Officer at Houghton Mifflin Harcourt Publishing Co. and as the Chief Financial Officer, Treasurer & VP at Applera Corp.
from 1995 to 1997.
He was also the Chief Financial Officer & Executive Vice President at Clinical Communications Group from 1997 to 1998.
Mr. Jaeger holds an MBA degree from Rutgers State University of New Jersey and an undergraduate degree from Fairfield University.
Postes actifs de Stephen Jaeger
| Sociétés | Poste | Début |
|---|---|---|
| TRAUMHAUS AG | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Stephen Jaeger
| Sociétés | Poste | Fin |
|---|---|---|
| DARA BIOSCIENCES INC | Director/Board Member | 30/11/2013 |
| ARADIGM CORPORATION | Director/Board Member | 28/12/2007 |
| eBT International, Inc. | Chairman | 01/12/2005 |
Clinical Communications Group
 Clinical Communications Group Miscellaneous Commercial ServicesCommercial Services Part of Vivendi SE, Clinical Communications Group is a private company that provides outsourced marketing services. The company is based in Greenwich, CT. Clinical Communications Group was acquired by Snyder Communications, Inc., part of Vivendi SE from September 27, 2000 on August 27, 1998 for $108 million. | Director of Finance/CFO | 01/01/1998 |
Applera Corp.
 Applera Corp. Medical SpecialtiesHealth Technology Applera Corp. manufactures medical instruments | Director of Finance/CFO | 01/01/1997 |
Formation de Stephen Jaeger
| Rutgers State University of New Jersey | Masters Business Admin |
| Fairfield University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TRAUMHAUS AG | Consumer Durables |
| Entreprise privées | 7 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
Houghton Mifflin Harcourt Publishing Co.
 Houghton Mifflin Harcourt Publishing Co. Information Technology ServicesTechnology Services Houghton Mifflin Harcourt Publishing Co. is a learning company, which engages in instructional curriculum, assessment, technology, and professional learning. The company was founded in 1832 by William Ticknor and James Fields and is headquartered in Boston, MA. | Technology Services |
| eBT International, Inc. | Technology Services |
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA. | Health Technology |
Applera Corp.
Applera Corp. Medical SpecialtiesHealth Technology Applera Corp. manufactures medical instruments | Health Technology |
Clinical Communications Group
Clinical Communications Group Miscellaneous Commercial ServicesCommercial Services Part of Vivendi SE, Clinical Communications Group is a private company that provides outsourced marketing services. The company is based in Greenwich, CT. Clinical Communications Group was acquired by Snyder Communications, Inc., part of Vivendi SE from September 27, 2000 on August 27, 1998 for $108 million. | Commercial Services |
DARA BioSciences, Inc.
 DARA BioSciences, Inc. Pharmaceuticals: MajorHealth Technology DARA BioSciences, Inc. is a pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care products. The company's product portfolio includes Soltamox, Gelclair, Bionect and KRN5500. Soltamox offers a choice to patients who prefer or need a liquid form of tamoxifen. Gelclair is an alcohol-free bioadherent oral rinse gel for rapid and effective relief of pain associated with oral mucositis caused by chemotherapy and radiation treatment. The company markets Bionect, a topical treatment for skin irritation and burns associated with radiation therapy, in U.S. oncology/radiology markets. DARA BioSciences was founded by Steven Gorlin on June 22, 2002 and is headquartered in Raleigh, NC. | Health Technology |
